PB is activated using near-infrared radiation to strongly attack most cancer cells, and CA4 limits the energy supply; this strategy overcomes inadequate tumor growth suppression due to limited laser penetration depth and provides proof of concept for the “attack + guard” strategy (Figure 4C) [109]. The gene discussed is CA4; the disease is neoplasm.